Do not purchase or use Captomer or Captomer-250
San Diego, CA (PRWEB) June 17, 2014
AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on dietary supplements.
The FDA warned consumers on June 13, not to purchase or use Captomer and Captomer-250, by Thorne Research, due to potential health risks. Captomer and Captomer-250 are promoted as dietary supplements for heavy metal toxicity and heavy metal chelation therapy.
FDA’s reason for the warning is that procedures involving chelation agents carry significant risks and should be performed only under medical supervision. These products contain DMSA (meso-2, 3-dimercaptosuccinic acid), an active ingredient in an FDA-approved prescription product indicated for the treatment of lead poisoning in children.
Taking into consideration the latest developments, AttorneyOne.com monitor daily and update the website providing accurate information on all relevant FDA safety alerts. Sean Burke, director of Media Relations at AttorneyOne.com, adds “we are determined to keep an eye on FDA announcements concerning dietary supplements and inform the public. For that reason", he continues, "our focus should squarely fall on investigating these safety alerts and getting the word out.”
The FDA advises consumers “Do not purchase or use Captomer or Captomer-250. Avoid all products offered over-the-counter (OTC) for chelation or detoxification.”
AttorneyOne.com has further information on dietary supplements at the website including latest major drug and medical products law news.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2014/06/prweb11941875.htm